Prestige Consumer Healthcare (PBH) Operating Expenses (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Operating Expenses of $74.9 million for Q4 2025, up 8.38% year-over-year from $69.1 million in Q4 2024, and up 4.13% quarter-over-quarter from $71.9 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Operating Expenses (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Operating Expenses history runs 16 years deep, the most recent figure standing at $74.9 million for Q4 2025.
- In Q4 2025, Operating Expenses rose 8.38% year-over-year to $74.9 million; the TTM figure through Dec 2025 stood at $296.9 million (up 3.91% YoY), while the FY2025 annual figure was $297.7 million, up 5.56% from the prior year.
- Operating Expenses for Q4 2025 stood at $74.9 million, up from $71.9 million in the prior quarter.
- The five-year high for Operating Expenses was $434.8 million in Q1 2023, with the low at $63.2 million in Q4 2022.
- The 5-year median for Operating Expenses is $71.8 million (2023), against an average of $90.0 million.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses soared 508.59% in 2023, then sank 83.98% in 2024.
- Prestige Consumer Healthcare's Operating Expenses stood at $72.5 million in 2021, then dropped by 12.76% to $63.2 million in 2022, then climbed by 12.48% to $71.1 million in 2023, then fell by 2.84% to $69.1 million in 2024, then grew by 8.38% to $74.9 million in 2025.
- Business Quant data shows PBH's Operating Expenses at $74.9 million in Q4 2025, $71.9 million in Q3 2025, and $68.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.42 Bn | 2.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 74.88 Mn |
| Sep 30, 2025 | 71.91 Mn |
| Jun 30, 2025 | 68.58 Mn |
| Mar 31, 2025 | 81.58 Mn |
| Dec 31, 2024 | 69.09 Mn |
| Sep 30, 2024 | 73.04 Mn |
| Jun 30, 2024 | 73.98 Mn |
| Mar 31, 2024 | 69.66 Mn |
| Dec 31, 2023 | 71.11 Mn |
| Sep 30, 2023 | 71.77 Mn |
| Jun 30, 2023 | 69.48 Mn |
| Mar 31, 2023 | 434.76 Mn |
| Dec 31, 2022 | 63.22 Mn |
| Sep 30, 2022 | 76.63 Mn |
| Jun 30, 2022 | 73.11 Mn |
| Mar 31, 2022 | 71.44 Mn |
| Dec 31, 2021 | 72.47 Mn |
| Sep 30, 2021 | 79.15 Mn |
| Jun 30, 2021 | 67.67 Mn |
| Mar 31, 2021 | 66.12 Mn |